Spray dried dispersion (SDD) is a commonly used technology to increase the bioavailability of poorly water-soluble compounds. Our integrated API and drug product spray drying service with highly-experienced cross-functional teams can accelerate development with in-parallel activities, delivering a fast and cost-effective approach to develop your molecule from preclinical to commercial.

Our state-of-the-art equipment and facilities enable seamless spray drying development and manufacturing from lab scale (50 mg – 1 kg) through to clinical and commercial production stage (1-100+ kg). We use four types of spray dryers (PSD-1, PSD-2, PSD-3, and PSD-4) to process compounds.

With high demand from clients globally, we are continuously expanding our capacity.

Our SDD drug product platform supports various dosage forms including tablets, capsules, powder, and granules.

Our highly experienced spray drying team has produced over 150 batches in 2023.

PSD-3 equipment

Spray drying capability from lab scale to production scale with successful commercial launch experience

Experienced with all SDD polymers and solvents



Selected Past Projects:

Scroll to Top
Please enable JavaScript in your browser to complete this form.